Partner with us icon Partner with Us
IPO Synopsis
Q-Line Biotech Ltd
Initial public offer of upto 62,53,200 equity shares of face value of Rs. 10/- each (the "Equity Shares") of Q-Line Biotech Limited ("the Company" or "QLBL" or "the Issuer") at an issue price of Rs. 343 per equity share (including share premium of Rs. 333 per equity share) for cash, aggregating up to Rs. 214.48 Crores ("Public Issue") out of which 3,13,200 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 343 per equity share for cash, aggregating Rs. 10.74 Crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. Issue of 59,40,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 343 per equity share for cash, aggregating upto Rs. 203.74 Crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.81% and 25.46% respectively of the post- issue paid-up equity share capital of the company. The company, in consultation with the book running lead managers, may consider a pre-ipo placement of up to 8,00,000 equity shares for cash consideration ("pre-ipo placement") prior to filing of the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the book running lead managers. If the pre-ipo placement is undertaken, the number of equity shares issued pursuant to the pre-ipo placement shall be reduced from the issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) rules, 1957, as amended ("scrr"). Price Band: Rs. 343 per equity share of face value Rs. 10/- each. The floor price (Rs.343) is 34.3 times of the face value of the equity shares. Bids can be made for a minimum of 800 equity shares and in multiples of 400 equity shares thereafter.
Issue
Opens On Closes On
21-May-26 25-May-26
Money Payable On
Application Allotment
343.00 0.00
Minimum Application for shares in Nos : 800 Further Multiples of : 400
Cr Lead Managers to the Issue
Project Cost (.Cr) 0.00 Hem Securities Limited
Project Financed through Current Offer (.Cr) 214.48  
Post Issue Equity Share Capital (.Cr) 23.33
Issue Price () 343.00
Projects
To meet Working Capital requirements
Repayment of certain borrowing availed by the Company, in part or full
General corporate purposes
Promoted By
Saurabh Garg
Amita Garg
Ayush Garg
Listing At
NSE - SME
Registrar to the Issue
No Data Available

Attention Investors:
Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. || Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. || Pay 20% upfront margin of the transaction value to trade in cash market segment. || Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. || Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. || KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. || No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.